Sign Out
Pregnancy: This product should be used in pregnant women or women who may possibly be pregnant only if the expected therapeutic benefits outweigh the possible risks associated with treatment. Hypocarnitinemia has been reported in women who have taken antibiotics containing a pivoxil group during the last trimester of pregnancy, as well as in the neonates born to them.
Lactation: 200 mg tablet: There is insufficient evidence available on whether cefditoren is present in human milk. Therefore, the administration of MEIACT is not recommended during lactation.
Continue with Google